Showing results (231-240 of 3,727) with videos related to
Sort By:
Pageof 373
Urology|December 1, 1986
Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancerH W Herr, R P Warrel, J H BurchenalToxicology and Applied Pharmacology|October 1, 1989
Blockade of only spinal alpha 1 adrenoceptors is insufficient to attenuate DDT-induced alterations in motor functionD W Herr, R B Mailman, H A TilsonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcomeH W Herr, D F Bajorin, H I ScherThe Urologic Clinics of North America|February 1, 1993
Fertility and testis cancerJ C Presti, H W Herr, P R CarrollThe Journal of Urology|October 1, 1996
Upper tract tumors in patients with primary bladder cancer followed for 15 yearsH W Herr, M S Cookson, S M SolowayThe Journal of Urology|March 11, 1976
Prognostic significance of regional lymph node histology in cancer of the bladderH W Herr, M A Bean, W F WhitmoreThe Journal of Urology|February 15, 2001
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancerH W Herr, S M Donat, D F BajorinThe Journal of Urology|November 7, 2001
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimensB H Bochner, H W Herr, V E ReuterThe Journal of Urology|January 1, 1975
External sphincterotomy in traumatic and non-traumatic neurogenic bladder dysfunctionH W Herr, E R Engelman, D C MartinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factorsFarhang Rabbani, Harry W Herr, Taghreed Almahmeed, et al.Pageof 373